Ignite Creation Date:
2024-05-06 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 12:47 PM
Study NCT ID:
NCT03546309
Status:
RECRUITING
Last Update Posted:
2019-11-20
First Post:
2018-03-12
Brief Title:
Safety and Efficacy of RIC in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy
Sponsor:
Capital Medical University
Organization:
Capital Medical University
Study Overview
Official Title:
Safety and Efficacy of Remote Ischemic Conditioning in Pediatric Moyamoya Disease Patients Treated With Revascularization Therapy
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
RIC-PMD
Brief Summary:
Revascularization surgery has been the standard treatment to prevent ischemic stroke in pediatric Moyamoya disease MMD patients with ischemic symptoms However perioperative complications such as hyperperfusion syndrome new infarct on imaging or ischemic stroke are inevitable Remote ischemic conditioning RIC is a noninvasive and easy-to-use neuroprotective strategy and it has potential effects on preventing hyperperfusion syndrome and ischemic infarction
Detailed Description:
This study will provide insights into the preliminary proof of principle safety and efficacy of RIC in pediatric MMD patients undergoing revascularization surgery therapy and this data will provide parameters for future larger scale clinical trials if efficacious
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None